The global Artificial Intelligence (AI) in Healthcare market size was valued at US$ 2174.1 million in 2023. With growing demand in downstream market, the Artificial Intelligence (AI) in Healthcare is forecast to a readjusted size of US$ 13330 million by 2030 with a CAGR of 29.6% during review period.
The research report highlights the growth potential of the global Artificial Intelligence (AI) in Healthcare market. Artificial Intelligence (AI) in Healthcare are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Artificial Intelligence (AI) in Healthcare. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Artificial Intelligence (AI) in Healthcare market.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Artificial Intelligence (AI) in Healthcare market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Artificial Intelligence (AI) in Healthcare market. It may include historical data, market segmentation by Type (e.g., Deep Learning, Querying Method), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Artificial Intelligence (AI) in Healthcare market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Artificial Intelligence (AI) in Healthcare market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Artificial Intelligence (AI) in Healthcare industry. This include advancements in Artificial Intelligence (AI) in Healthcare technology, Artificial Intelligence (AI) in Healthcare new entrants, Artificial Intelligence (AI) in Healthcare new investment, and other innovations that are shaping the future of Artificial Intelligence (AI) in Healthcare.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Artificial Intelligence (AI) in Healthcare market. It includes factors influencing customer ' purchasing decisions, preferences for Artificial Intelligence (AI) in Healthcare product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Artificial Intelligence (AI) in Healthcare market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Artificial Intelligence (AI) in Healthcare market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Artificial Intelligence (AI) in Healthcare market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Artificial Intelligence (AI) in Healthcare industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Artificial Intelligence (AI) in Healthcare market.
麻豆原创 Segmentation:
Artificial Intelligence (AI) in Healthcare market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Deep Learning
Querying Method
Natural Language Processing
Context Aware Processing
Other
Segmentation by application
Hospitals
Clinics
Research Institutions
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Intel Corporation
Nvidia Corporation
Google
IBM Corporation
Microsoft Corporation
General Vision
Enlitic
Next IT
Welltok
Icarbonx
Recursion Pharmaceuticals
Koninklijke Philips
General Electric (GE) Company
Siemens Healthineers (A Division of Siemens AG)
Johnson & Johnson Services
Medtronic
Stryker Corporation
Careskore
Zephyr Health
Oncora Medical
Sentrian
Bay Labs
Atomwise
Deep Genomics
Cloudmedx
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Artificial Intelligence (AI) in Healthcare 麻豆原创 Size 2019-2030
2.1.2 Artificial Intelligence (AI) in Healthcare 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Artificial Intelligence (AI) in Healthcare Segment by Type
2.2.1 Deep Learning
2.2.2 Querying Method
2.2.3 Natural Language Processing
2.2.4 Context Aware Processing
2.2.5 Other
2.3 Artificial Intelligence (AI) in Healthcare 麻豆原创 Size by Type
2.3.1 Artificial Intelligence (AI) in Healthcare 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Artificial Intelligence (AI) in Healthcare 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Artificial Intelligence (AI) in Healthcare Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Research Institutions
2.4.4 Other
2.5 Artificial Intelligence (AI) in Healthcare 麻豆原创 Size by Application
2.5.1 Artificial Intelligence (AI) in Healthcare 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Artificial Intelligence (AI) in Healthcare 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Artificial Intelligence (AI) in Healthcare 麻豆原创 Size by Player
3.1 Artificial Intelligence (AI) in Healthcare 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Artificial Intelligence (AI) in Healthcare Revenue by Players (2019-2024)
3.1.2 Global Artificial Intelligence (AI) in Healthcare Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Artificial Intelligence (AI) in Healthcare Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Artificial Intelligence (AI) in Healthcare by Regions
4.1 Artificial Intelligence (AI) in Healthcare 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Artificial Intelligence (AI) in Healthcare 麻豆原创 Size Growth (2019-2024)
4.3 APAC Artificial Intelligence (AI) in Healthcare 麻豆原创 Size Growth (2019-2024)
4.4 Europe Artificial Intelligence (AI) in Healthcare 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Artificial Intelligence (AI) in Healthcare 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Artificial Intelligence (AI) in Healthcare 麻豆原创 Size by Country (2019-2024)
5.2 Americas Artificial Intelligence (AI) in Healthcare 麻豆原创 Size by Type (2019-2024)
5.3 Americas Artificial Intelligence (AI) in Healthcare 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence (AI) in Healthcare 麻豆原创 Size by Region (2019-2024)
6.2 APAC Artificial Intelligence (AI) in Healthcare 麻豆原创 Size by Type (2019-2024)
6.3 APAC Artificial Intelligence (AI) in Healthcare 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Artificial Intelligence (AI) in Healthcare by Country (2019-2024)
7.2 Europe Artificial Intelligence (AI) in Healthcare 麻豆原创 Size by Type (2019-2024)
7.3 Europe Artificial Intelligence (AI) in Healthcare 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artificial Intelligence (AI) in Healthcare by Region (2019-2024)
8.2 Middle East & Africa Artificial Intelligence (AI) in Healthcare 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Artificial Intelligence (AI) in Healthcare 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.1 Global Artificial Intelligence (AI) in Healthcare Forecast by Regions (2025-2030)
10.1.1 Global Artificial Intelligence (AI) in Healthcare Forecast by Regions (2025-2030)
10.1.2 Americas Artificial Intelligence (AI) in Healthcare Forecast
10.1.3 APAC Artificial Intelligence (AI) in Healthcare Forecast
10.1.4 Europe Artificial Intelligence (AI) in Healthcare Forecast
10.1.5 Middle East & Africa Artificial Intelligence (AI) in Healthcare Forecast
10.2 Americas Artificial Intelligence (AI) in Healthcare Forecast by Country (2025-2030)
10.2.1 United States Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.2.2 Canada Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.2.3 Mexico Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.2.4 Brazil Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.3 APAC Artificial Intelligence (AI) in Healthcare Forecast by Region (2025-2030)
10.3.1 China Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.3.2 Japan Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.3.3 Korea Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.3.4 Southeast Asia Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.3.5 India Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.3.6 Australia Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.4 Europe Artificial Intelligence (AI) in Healthcare Forecast by Country (2025-2030)
10.4.1 Germany Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.4.2 France Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.4.3 UK Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.4.4 Italy Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.4.5 Russia Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.5 Middle East & Africa Artificial Intelligence (AI) in Healthcare Forecast by Region (2025-2030)
10.5.1 Egypt Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.5.2 South Africa Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.5.3 Israel Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.5.4 Turkey Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.5.5 GCC Countries Artificial Intelligence (AI) in Healthcare 麻豆原创 Forecast
10.6 Global Artificial Intelligence (AI) in Healthcare Forecast by Type (2025-2030)
10.7 Global Artificial Intelligence (AI) in Healthcare Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Intel Corporation
11.1.1 Intel Corporation Company Information
11.1.2 Intel Corporation Artificial Intelligence (AI) in Healthcare Product Offered
11.1.3 Intel Corporation Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Intel Corporation Main Business Overview
11.1.5 Intel Corporation Latest Developments
11.2 Nvidia Corporation
11.2.1 Nvidia Corporation Company Information
11.2.2 Nvidia Corporation Artificial Intelligence (AI) in Healthcare Product Offered
11.2.3 Nvidia Corporation Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Nvidia Corporation Main Business Overview
11.2.5 Nvidia Corporation Latest Developments
11.3 Google
11.3.1 Google Company Information
11.3.2 Google Artificial Intelligence (AI) in Healthcare Product Offered
11.3.3 Google Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Google Main Business Overview
11.3.5 Google Latest Developments
11.4 IBM Corporation
11.4.1 IBM Corporation Company Information
11.4.2 IBM Corporation Artificial Intelligence (AI) in Healthcare Product Offered
11.4.3 IBM Corporation Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 IBM Corporation Main Business Overview
11.4.5 IBM Corporation Latest Developments
11.5 Microsoft Corporation
11.5.1 Microsoft Corporation Company Information
11.5.2 Microsoft Corporation Artificial Intelligence (AI) in Healthcare Product Offered
11.5.3 Microsoft Corporation Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Microsoft Corporation Main Business Overview
11.5.5 Microsoft Corporation Latest Developments
11.6 General Vision
11.6.1 General Vision Company Information
11.6.2 General Vision Artificial Intelligence (AI) in Healthcare Product Offered
11.6.3 General Vision Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 General Vision Main Business Overview
11.6.5 General Vision Latest Developments
11.7 Enlitic
11.7.1 Enlitic Company Information
11.7.2 Enlitic Artificial Intelligence (AI) in Healthcare Product Offered
11.7.3 Enlitic Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Enlitic Main Business Overview
11.7.5 Enlitic Latest Developments
11.8 Next IT
11.8.1 Next IT Company Information
11.8.2 Next IT Artificial Intelligence (AI) in Healthcare Product Offered
11.8.3 Next IT Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Next IT Main Business Overview
11.8.5 Next IT Latest Developments
11.9 Welltok
11.9.1 Welltok Company Information
11.9.2 Welltok Artificial Intelligence (AI) in Healthcare Product Offered
11.9.3 Welltok Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Welltok Main Business Overview
11.9.5 Welltok Latest Developments
11.10 Icarbonx
11.10.1 Icarbonx Company Information
11.10.2 Icarbonx Artificial Intelligence (AI) in Healthcare Product Offered
11.10.3 Icarbonx Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Icarbonx Main Business Overview
11.10.5 Icarbonx Latest Developments
11.11 Recursion Pharmaceuticals
11.11.1 Recursion Pharmaceuticals Company Information
11.11.2 Recursion Pharmaceuticals Artificial Intelligence (AI) in Healthcare Product Offered
11.11.3 Recursion Pharmaceuticals Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Recursion Pharmaceuticals Main Business Overview
11.11.5 Recursion Pharmaceuticals Latest Developments
11.12 Koninklijke Philips
11.12.1 Koninklijke Philips Company Information
11.12.2 Koninklijke Philips Artificial Intelligence (AI) in Healthcare Product Offered
11.12.3 Koninklijke Philips Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Koninklijke Philips Main Business Overview
11.12.5 Koninklijke Philips Latest Developments
11.13 General Electric (GE) Company
11.13.1 General Electric (GE) Company Company Information
11.13.2 General Electric (GE) Company Artificial Intelligence (AI) in Healthcare Product Offered
11.13.3 General Electric (GE) Company Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 General Electric (GE) Company Main Business Overview
11.13.5 General Electric (GE) Company Latest Developments
11.14 Siemens Healthineers (A Division of Siemens AG)
11.14.1 Siemens Healthineers (A Division of Siemens AG) Company Information
11.14.2 Siemens Healthineers (A Division of Siemens AG) Artificial Intelligence (AI) in Healthcare Product Offered
11.14.3 Siemens Healthineers (A Division of Siemens AG) Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 Siemens Healthineers (A Division of Siemens AG) Main Business Overview
11.14.5 Siemens Healthineers (A Division of Siemens AG) Latest Developments
11.15 Johnson & Johnson Services
11.15.1 Johnson & Johnson Services Company Information
11.15.2 Johnson & Johnson Services Artificial Intelligence (AI) in Healthcare Product Offered
11.15.3 Johnson & Johnson Services Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 Johnson & Johnson Services Main Business Overview
11.15.5 Johnson & Johnson Services Latest Developments
11.16 Medtronic
11.16.1 Medtronic Company Information
11.16.2 Medtronic Artificial Intelligence (AI) in Healthcare Product Offered
11.16.3 Medtronic Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.16.4 Medtronic Main Business Overview
11.16.5 Medtronic Latest Developments
11.17 Stryker Corporation
11.17.1 Stryker Corporation Company Information
11.17.2 Stryker Corporation Artificial Intelligence (AI) in Healthcare Product Offered
11.17.3 Stryker Corporation Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.17.4 Stryker Corporation Main Business Overview
11.17.5 Stryker Corporation Latest Developments
11.18 Careskore
11.18.1 Careskore Company Information
11.18.2 Careskore Artificial Intelligence (AI) in Healthcare Product Offered
11.18.3 Careskore Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.18.4 Careskore Main Business Overview
11.18.5 Careskore Latest Developments
11.19 Zephyr Health
11.19.1 Zephyr Health Company Information
11.19.2 Zephyr Health Artificial Intelligence (AI) in Healthcare Product Offered
11.19.3 Zephyr Health Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.19.4 Zephyr Health Main Business Overview
11.19.5 Zephyr Health Latest Developments
11.20 Oncora Medical
11.20.1 Oncora Medical Company Information
11.20.2 Oncora Medical Artificial Intelligence (AI) in Healthcare Product Offered
11.20.3 Oncora Medical Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.20.4 Oncora Medical Main Business Overview
11.20.5 Oncora Medical Latest Developments
11.21 Sentrian
11.21.1 Sentrian Company Information
11.21.2 Sentrian Artificial Intelligence (AI) in Healthcare Product Offered
11.21.3 Sentrian Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.21.4 Sentrian Main Business Overview
11.21.5 Sentrian Latest Developments
11.22 Bay Labs
11.22.1 Bay Labs Company Information
11.22.2 Bay Labs Artificial Intelligence (AI) in Healthcare Product Offered
11.22.3 Bay Labs Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.22.4 Bay Labs Main Business Overview
11.22.5 Bay Labs Latest Developments
11.23 Atomwise
11.23.1 Atomwise Company Information
11.23.2 Atomwise Artificial Intelligence (AI) in Healthcare Product Offered
11.23.3 Atomwise Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.23.4 Atomwise Main Business Overview
11.23.5 Atomwise Latest Developments
11.24 Deep Genomics
11.24.1 Deep Genomics Company Information
11.24.2 Deep Genomics Artificial Intelligence (AI) in Healthcare Product Offered
11.24.3 Deep Genomics Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.24.4 Deep Genomics Main Business Overview
11.24.5 Deep Genomics Latest Developments
11.25 Cloudmedx
11.25.1 Cloudmedx Company Information
11.25.2 Cloudmedx Artificial Intelligence (AI) in Healthcare Product Offered
11.25.3 Cloudmedx Artificial Intelligence (AI) in Healthcare Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.25.4 Cloudmedx Main Business Overview
11.25.5 Cloudmedx Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
